New Intravenous Anaesthetics and Neuromuscular Blocking Drugs

@article{Reilly2012NewIA,
  title={New Intravenous Anaesthetics and Neuromuscular Blocking Drugs},
  author={C. S. Reilly and W. Nimmo},
  journal={Drugs},
  year={2012},
  volume={34},
  pages={98-135}
}
  • C. S. Reilly, W. Nimmo
  • Published 2012
  • Medicine
  • Drugs
    • SummaryThe newer neuromuscular blocking drugs include vecuronium and atracurium. Vecuronium is a competitive neuromuscular blocking drug with a steroid nucleus. A dose of 0.1 mg/kg has an onset time of 2 minutes and provides surgical paralysis for 20 minutes. Recovery to 90% twitch height occurs in 40 to 50 minutes. Vecuronium has few adverse effects and its use is associated with cardiovascular stability. Atracurium is a competitive neuromuscular blocking drug which undergoes Hofmann… CONTINUE READING
    View on Springer
    Top 3 of 3 Citations
    Full-Cost Determination of Different Levels of Care in the Intensive Care Unit
    J. Doyle, Julian P. Casciano, … J. E. PaulPharmacoEconomics2012
    3
    Effect of dexmedetomidine with or without butorphanol on the clinico-physiological and haemodynamic stability in dogs undergoing ovariohysterectomy in midazolam and ketamine anaesthesia
    Malik Abu Rafee, P. Kinjavdekar, … H. P. Aithal2015
    Safety of intravenous and inhalation anesthetics
    L. Arendt-Nielsen2013
    3 Citations
    Citation Type

    Citation Type

    Full-Cost Determination of Different Levels of Care in the Intensive Care Unit
    • 3
    Effect of dexmedetomidine with or without butorphanol on the clinico-physiological and haemodynamic stability in dogs undergoing ovariohysterectomy in midazolam and ketamine anaesthesia
    Safety of intravenous and inhalation anesthetics

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 398 REFERENCES
    The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study.
    • 126
    Evaluation of atracurium in anaesthetized man.
    • 158
    • PDF
    Clinical Pharmacology of Atracurium Besylate (BW 33A): A New Non‐depolarizing Muscle Relaxant
    • 156
    Clinical comparison of atracurium and vecuronium (Org NC 45).
    • 78
    Animal studies of the anaesthetic activity of ICI 35 868.
    • 218
    • PDF
    Edrophonium: Duration of Action and Atropine Requirement in Humans during Halothane Anesthesia
    • 111
    The pharmacology of atracurium: a new competitive neuromuscular blocking agent.
    • 172
    • PDF
    Verapamil and reversal of vecuronium neuromuscular blockade.
    • 40
    Neuromuscular Effects of Atracurium in Man
    • 58
    The Pharmacokinetics and Pharmacodynamics of Atracurium in Patients with and without Renal Failure
    • 119